CStone Pharma hires Richard Yeh as CFO
CStone Pharmaceuticals, a biopharmaceutical company devoted to developing a new generation of innovative drugs, recently announced the appointment of Richard Yeh as Chief Financial Officer (CFO), reporting to Dr Frank Jiang, Chief Executive Officer of CStone. Yeh brings vast and deep experience in the pharmaceutical and biotechnology finance sectors and will provide a strong addition to CStone’s senior leadership ranks. As the CFO of CStone, Yeh will develop corporate financial strategies, and oversee financial reporting, risk management, funding, and IPO. His in-depth understanding of the industry will help further cement CStone’s position among leading innovative biopharmaceutical companies in China. Prior to joining CStone, Yeh was the managing director and the business unit leader of Asia Pacific Healthcare equity research at Goldman Sachs. He led the firm’s research efforts on the Chinese and Asia healthcare market. Before that, Yeh served as the head of the regional healthcare research team at Citigroup.